Clinical Development

cGMP Drug Manufacture - Development and supply of proprietary peptide APIs (peptide-based active pharmaceutical ingredient) for drug and vaccine clinical trials

Demand for peptide-based APIs is increasing, and needs of pharmaceutical companies constantly changing. Our customers require access to a broad spectrum of capabilities, and have different attitudes to geographic location of manufacturing which affects costs. In order to meet these diverse needs, Cambridge Peptides has pursued a strategy of building global relationships with international suppliers of contract manufacturing services in the US, Europe, India and East Asia (including China and Japan). This allows us to meet the precise needs of our customers by optimally matching customer needs with the capabilities and particular strengths of individual suppliers around the world. We offer unbiased advice, select and contract manufacturers, and work closely with your internal project managers to ensure that milestones are met on time and within budget.